Tissue Regenix Group Plc is a medical technology company, which develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine. It operates through BioSurgery, Orthopaedics & Dental, Cardiac and Other divisions. Its patented decellularisation technology removes DNA and other cellular material from animal and human tissue leaving a cellular tissue scaffold, which is not rejected by the patient's body which can then be used to repair diseased and worn out body parts. The company was founded by Eileen Ingham and John Fisher on May 5, 2006 and is headquartered in Leeds, the United Kingdom.
Tissue Regenix Group PLC LON:TRX
Today's live share price, quote history, chart & news
|Year to date change||-100.00%|
About Tissue Regenix Group PLC
Tissue Regenix Group Plc
Miscellaneous Commercial Services
Gareth Hywel Jones
Astley Lane Industrial Estate, Astley Way Unit 1&2, Swillington, Leeds, Yorkshire, LS26
|Entity name||Report date||Shares held|
Aggregated insiders summary data for the last 6 months.
|Full name||Reported title||Total bought||Total sold||Net transacted|
|Full name||Reported title||Effective date||Amount of shares||Price per share||Total cost|
Tissue Regenix Group PLC dividends
|Ex date||Payment date||Record date||Declared date||Amount||Description||Frequency|